title: The incidence and reporting of adverse drug reactions in the Division of Psychiatry.
abstract: OBJECTIVE
  To determine the incidence, severity and reporting of adverse drug reactions occurring to newly marketed drug (all drugs annotated with a black triangle symbol) in the Division of Psychiatry.
  
  
  METHODS
  All patient commenced on a black triangle drug in the previous month and satisfying all inclusion criteria were interviewed by a pre-registration pharmacist. The investigator collected details regarding drug prescribed, side effects reported and non-compliance. Reports sent to the CSM were noted.
  
  
  RESULTS
  Twenty-two patients received 25 black triangle drugs. Sixteen (60%) suffered an adverse drug reaction. Eight reported these to their doctor with 7 (28%) discontinuing treatment due to the severity of the side effects. Two adverse drugs reactions were classified as serious according to CSM criteria (jerking movements, rash), 3 further reactions led to a deterioration in the patients mental state. No yellow cards were completed.
  
  
  CONCLUSIONS
  Both patient and health care professionals underreport adverse drug reactions. All reactions to a black triangle drug should be reported. A medicines and healthy living group attended by patients and professionals involved in their case has allowed an increased awareness, monitoring and reporting of adverse drug reactions.
authors.affiliation: Department of Psychiatry, Manchester Royal Infirmary, Oxford Road, Manchester, M13-9WL, UK. petra@psy.cmht.nwest.nhs.uk
authors.forename: P
authors.initials: P
authors.lastname: Brown
authors.forename: L
authors.initials: L
authors.lastname: Faloon
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems / Q000706:statistics & numerical data*; D006282:Health Personnel / Q000523:psychology / Q000706:statistics & numerical data; D006801:Humans; D015994:Incidence; D010358:Patient Participation / Q000523:psychology / Q000706:statistics & numerical data; D011567:Psychiatric Department, Hospital / Q000706:statistics & numerical data*; D011619:Psychotropic Drugs / Q000009:adverse effects
chemical_list: D011619:Psychotropic Drugs